Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Prostatic Neoplasms 3Recurrence 1Rectal Neoplasms 1Neuroendocrine Tumors 1Melanoma 1Lymphoma, T-Cell, Peripheral 1Leukemia, Myeloid, Acute 1Leukemia, Erythroblastic, Acute 1Hodgkin Disease 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Cytarabine 34Busulfan 17Cyclophosphamide 16fludarabine phosphate 15Peripheral Blood Stem Cell Transplantation 13Filgrastim 13Etoposide 13Idarubicin 12Mitoxantrone 9Cyclosporine 9Antilymphocyte Serum 9Methotrexate 8Daunorubicin 8Whole-Body Irradiation 6Radiotherapy 6Tacrolimus 5Cord Blood Stem Cell Transplantation 5Clofarabine 5Mycophenolic Acid 4Methylprednisolone 4Melphalan 4Gemtuzumab 4Flow Cytometry 4Arsenic Trioxide 4aldesleukin 3Topotecan 3Imatinib Mesylate 3Cytogenetic Analysis 3Cyclosporins 3Bortezomib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Leukemia, Erythroblastic, Acute × Salvage Therapy × Clear all
NCT04424147 2022-10-26

Efficacy and Safety of HVA Regimens as Salvage Treatment in rrAML

Nanfang Hospital, Southern Medical University

Phase 2 Completed
96 enrolled
Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡